I think there are still some losses that they can offset against that revenue to keep it in our pockets.
I am still hopeful of seeing a dividend or some options issued. Would love some money but options would reward both me and the company if they perform how I am expecting. $3 options would be fair. - If they are listed it would allow those that want to cash in on them to do so. Win/Win.
Hi @bobsacramento Love seeing you drop by with your posts now and then. I think it is the possibilities that have always kept my excitement in this little company. Piecing together the puzzle keeps me interested..
I wonder how much debt Nemaska is carrying.. Galaxy could certainly use it as leverage if they were negotiating with them. - Nemaska have a very good partner in Johnson Matthey who picked up some assets of A123 in Jiangsu.
Nemaska's market cap does appear to be a little low considering this announcement. LINK
Sounds like they would be a nice little take over target and could match an expansion for Galaxy nicely.
Guy Bourassa would be a good addition to the team also, as he can comfortably speak with as much authority as Anthony Tse.
- Forums
- ASX - By Stock
- GXY
- Ann: Mt Cattlin Sales Update
Ann: Mt Cattlin Sales Update, page-58
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online